

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.98072687 |
| 2 | glutamate secretion (GO:0014047) | 5.44784416 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.39241596 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.38501012 |
| 5 | vocalization behavior (GO:0071625) | 5.29304172 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.24802459 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.10114616 |
| 8 | neuronal action potential propagation (GO:0019227) | 5.03775092 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.97582041 |
| 10 | synaptic vesicle maturation (GO:0016188) | 4.83103045 |
| 11 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.65987829 |
| 12 | locomotory exploration behavior (GO:0035641) | 4.61721340 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.61471707 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.57461597 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 4.55418727 |
| 16 | protein localization to synapse (GO:0035418) | 4.54786566 |
| 17 | neurotransmitter secretion (GO:0007269) | 4.52858029 |
| 18 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.49550575 |
| 19 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.40668337 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.38946900 |
| 21 | neuron cell-cell adhesion (GO:0007158) | 4.38224177 |
| 22 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.35956663 |
| 23 | neuron-neuron synaptic transmission (GO:0007270) | 4.24148418 |
| 24 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.13452161 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 4.12753862 |
| 26 | glutamate receptor signaling pathway (GO:0007215) | 4.06976401 |
| 27 | presynaptic membrane assembly (GO:0097105) | 3.97321534 |
| 28 | serotonin metabolic process (GO:0042428) | 3.84396057 |
| 29 | presynaptic membrane organization (GO:0097090) | 3.82109123 |
| 30 | long-term synaptic potentiation (GO:0060291) | 3.79922376 |
| 31 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.79811147 |
| 32 | cerebellar Purkinje cell layer development (GO:0021680) | 3.78323973 |
| 33 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.71290380 |
| 34 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.71100686 |
| 35 | neurotransmitter transport (GO:0006836) | 3.64834737 |
| 36 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.63803419 |
| 37 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.62443391 |
| 38 | positive regulation of synapse maturation (GO:0090129) | 3.61815696 |
| 39 | positive regulation of membrane potential (GO:0045838) | 3.58928607 |
| 40 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.58378994 |
| 41 | exploration behavior (GO:0035640) | 3.57846964 |
| 42 | detection of calcium ion (GO:0005513) | 3.55686175 |
| 43 | gamma-aminobutyric acid transport (GO:0015812) | 3.54370427 |
| 44 | regulation of postsynaptic membrane potential (GO:0060078) | 3.53878935 |
| 45 | cellular potassium ion homeostasis (GO:0030007) | 3.53036586 |
| 46 | synaptic vesicle endocytosis (GO:0048488) | 3.52170844 |
| 47 | regulation of neurotransmitter secretion (GO:0046928) | 3.51485851 |
| 48 | potassium ion homeostasis (GO:0055075) | 3.49883718 |
| 49 | response to histamine (GO:0034776) | 3.49814657 |
| 50 | postsynaptic membrane organization (GO:0001941) | 3.49333511 |
| 51 | regulation of synapse structural plasticity (GO:0051823) | 3.49041679 |
| 52 | membrane depolarization during action potential (GO:0086010) | 3.48642448 |
| 53 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.47199193 |
| 54 | long-term memory (GO:0007616) | 3.45026113 |
| 55 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.44029790 |
| 56 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.42452180 |
| 57 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.42452180 |
| 58 | primary amino compound metabolic process (GO:1901160) | 3.42193683 |
| 59 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.38430598 |
| 60 | neuromuscular process controlling posture (GO:0050884) | 3.38116562 |
| 61 | behavioral response to cocaine (GO:0048148) | 3.37404108 |
| 62 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.36876159 |
| 63 | regulation of neurotransmitter levels (GO:0001505) | 3.36105630 |
| 64 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.36045320 |
| 65 | sodium ion export (GO:0071436) | 3.35855509 |
| 66 | transferrin transport (GO:0033572) | 3.34476995 |
| 67 | regulation of synaptic plasticity (GO:0048167) | 3.34246668 |
| 68 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.32760851 |
| 69 | positive regulation of neurotransmitter transport (GO:0051590) | 3.32184118 |
| 70 | regulation of neurotransmitter transport (GO:0051588) | 3.32100824 |
| 71 | neurofilament cytoskeleton organization (GO:0060052) | 3.31911118 |
| 72 | startle response (GO:0001964) | 3.29633875 |
| 73 | regulation of vesicle fusion (GO:0031338) | 3.29615238 |
| 74 | membrane depolarization (GO:0051899) | 3.24327724 |
| 75 | long term synaptic depression (GO:0060292) | 3.23186577 |
| 76 | striatum development (GO:0021756) | 3.23179358 |
| 77 | short-term memory (GO:0007614) | 3.20647667 |
| 78 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.17685339 |
| 79 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.17578907 |
| 80 | proline transport (GO:0015824) | 3.16508733 |
| 81 | activation of protein kinase A activity (GO:0034199) | 3.13676610 |
| 82 | potassium ion import (GO:0010107) | 3.13094878 |
| 83 | synaptic transmission (GO:0007268) | 3.13090520 |
| 84 | dendritic spine morphogenesis (GO:0060997) | 3.12359582 |
| 85 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.11877504 |
| 86 | trivalent inorganic cation transport (GO:0072512) | 3.11464557 |
| 87 | ferric iron transport (GO:0015682) | 3.11464557 |
| 88 | prepulse inhibition (GO:0060134) | 3.09880627 |
| 89 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.08799549 |
| 90 | dopamine biosynthetic process (GO:0042416) | 3.07756686 |
| 91 | positive regulation of synaptic transmission (GO:0050806) | 3.07333943 |
| 92 | membrane hyperpolarization (GO:0060081) | 3.07119731 |
| 93 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.06576113 |
| 94 | cerebellar granule cell differentiation (GO:0021707) | 3.04995717 |
| 95 | C4-dicarboxylate transport (GO:0015740) | 3.04989840 |
| 96 | regulation of cell communication by electrical coupling (GO:0010649) | 3.04948002 |
| 97 | positive regulation of dendritic spine development (GO:0060999) | 3.04748231 |
| 98 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.04697241 |
| 99 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.03562796 |
| 100 | cellular ketone body metabolic process (GO:0046950) | 3.02438570 |
| 101 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.02178548 |
| 102 | regulation of synapse maturation (GO:0090128) | 3.01728999 |
| 103 | transmission of nerve impulse (GO:0019226) | 3.01270239 |
| 104 | regulation of dendritic spine development (GO:0060998) | 3.00971821 |
| 105 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.00252692 |
| 106 | alanine transport (GO:0032328) | 2.99023743 |
| 107 | righting reflex (GO:0060013) | 2.98195425 |
| 108 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.96120156 |
| 109 | cell communication by electrical coupling (GO:0010644) | 2.94003146 |
| 110 | establishment of synaptic vesicle localization (GO:0097480) | 2.93473548 |
| 111 | synaptic vesicle transport (GO:0048489) | 2.93473548 |
| 112 | regulation of synaptic transmission (GO:0050804) | 2.92994196 |
| 113 | cell differentiation in hindbrain (GO:0021533) | 2.92992978 |
| 114 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.92125526 |
| 115 | cellular sodium ion homeostasis (GO:0006883) | 2.92119350 |
| 116 | mechanosensory behavior (GO:0007638) | 2.91130581 |
| 117 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.90188904 |
| 118 | response to amphetamine (GO:0001975) | 2.90032514 |
| 119 | learning (GO:0007612) | 2.89853993 |
| 120 | layer formation in cerebral cortex (GO:0021819) | 2.87570394 |
| 121 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.87098869 |
| 122 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.86671516 |
| 123 | chemosensory behavior (GO:0007635) | 2.84048207 |
| 124 | innervation (GO:0060384) | 2.83733857 |
| 125 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.81011037 |
| 126 | insulin secretion (GO:0030073) | 2.80369266 |
| 127 | calcium ion-dependent exocytosis (GO:0017156) | 2.79947188 |
| 128 | signal release (GO:0023061) | 2.75716798 |
| 129 | neuronal action potential (GO:0019228) | 2.75146865 |
| 130 | regulation of dopamine metabolic process (GO:0042053) | 2.74484644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.70833339 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.45202641 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14307149 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02713975 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.88772026 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74849606 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.51970553 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.51667456 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.47507373 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.47507373 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.44409490 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39097199 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.36694305 |
| 14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.34788219 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.34469062 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33312404 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.28098932 |
| 18 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.26635306 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.23641338 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.14833456 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.14326675 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.06293327 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.06105007 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04780900 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.01869306 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99587322 |
| 27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.98688658 |
| 28 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.97060138 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.95489430 |
| 30 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.89250364 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88179858 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.88078799 |
| 33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.83327251 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80370591 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.79602972 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.79019160 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.71854107 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.67470868 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65507676 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.63767427 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.63521200 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58389650 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.58241837 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.55180894 |
| 45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.48478704 |
| 46 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.47847320 |
| 47 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46886827 |
| 48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.46884364 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43969896 |
| 50 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.43865377 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43002437 |
| 52 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.42624842 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.42529987 |
| 54 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42373949 |
| 55 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.41805671 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.37883297 |
| 57 | FUS_26573619_Chip-Seq_HEK293_Human | 1.33372008 |
| 58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32009081 |
| 59 | TCF4_23295773_ChIP-Seq_U87_Human | 1.30626499 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.26318023 |
| 61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25109349 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23754164 |
| 63 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22087233 |
| 64 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21498818 |
| 65 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18465059 |
| 66 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18057272 |
| 67 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.17862127 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17559731 |
| 69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16258443 |
| 70 | AR_19668381_ChIP-Seq_PC3_Human | 1.16071209 |
| 71 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.15674477 |
| 72 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.14116412 |
| 73 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12996567 |
| 74 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12614826 |
| 75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12405967 |
| 76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10697038 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10143394 |
| 78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09155330 |
| 79 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08946129 |
| 80 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07877631 |
| 81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07832077 |
| 82 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.07645433 |
| 83 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07432069 |
| 84 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06006573 |
| 85 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05940111 |
| 86 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05653816 |
| 87 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05495619 |
| 88 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05372675 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04573792 |
| 90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03897052 |
| 91 | JUN_21703547_ChIP-Seq_K562_Human | 1.03535202 |
| 92 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.03415913 |
| 93 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02995537 |
| 94 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01731181 |
| 95 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01607432 |
| 96 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.01351679 |
| 97 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00139584 |
| 98 | KDM2B_26808549_Chip-Seq_REH_Human | 0.99915327 |
| 99 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99902512 |
| 100 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99668389 |
| 101 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99380722 |
| 102 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98563640 |
| 103 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98441265 |
| 104 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.98419137 |
| 105 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.98413093 |
| 106 | EWS_26573619_Chip-Seq_HEK293_Human | 0.96282316 |
| 107 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.96224342 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95230292 |
| 109 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95063106 |
| 110 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95063106 |
| 111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94206449 |
| 112 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94190821 |
| 113 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.92943387 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92475657 |
| 115 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92440239 |
| 116 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91184218 |
| 117 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.90610108 |
| 118 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90273350 |
| 119 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90174435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.49028692 |
| 2 | MP0003880_abnormal_central_pattern | 5.01850954 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.87121378 |
| 4 | MP0009046_muscle_twitch | 3.68295985 |
| 5 | MP0009745_abnormal_behavioral_response | 3.39863751 |
| 6 | MP0004270_analgesia | 3.31594841 |
| 7 | MP0002064_seizures | 3.21531521 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.16812487 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.05616329 |
| 10 | MP0002272_abnormal_nervous_system | 2.79679210 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.74858899 |
| 12 | MP0002822_catalepsy | 2.72297910 |
| 13 | MP0002736_abnormal_nociception_after | 2.67955933 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.63102163 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.48219496 |
| 16 | MP0001486_abnormal_startle_reflex | 2.44775116 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.41428461 |
| 18 | MP0002067_abnormal_sensory_capabilities | 2.21511195 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.20210102 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.04571134 |
| 21 | MP0008569_lethality_at_weaning | 1.96729771 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.93048593 |
| 23 | MP0001970_abnormal_pain_threshold | 1.91539406 |
| 24 | MP0006276_abnormal_autonomic_nervous | 1.90437730 |
| 25 | MP0003879_abnormal_hair_cell | 1.88979454 |
| 26 | MP0002909_abnormal_adrenal_gland | 1.88844782 |
| 27 | MP0003787_abnormal_imprinting | 1.88593471 |
| 28 | MP0004924_abnormal_behavior | 1.86776964 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.86776964 |
| 30 | MP0001529_abnormal_vocalization | 1.85148262 |
| 31 | MP0002733_abnormal_thermal_nociception | 1.85118102 |
| 32 | MP0001984_abnormal_olfaction | 1.82841041 |
| 33 | MP0005423_abnormal_somatic_nervous | 1.81041774 |
| 34 | MP0001188_hyperpigmentation | 1.76492904 |
| 35 | MP0000751_myopathy | 1.73881809 |
| 36 | MP0003646_muscle_fatigue | 1.72895569 |
| 37 | MP0004215_abnormal_myocardial_fiber | 1.68535782 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.65382722 |
| 39 | MP0002184_abnormal_innervation | 1.64253369 |
| 40 | MP0001905_abnormal_dopamine_level | 1.55098710 |
| 41 | MP0004142_abnormal_muscle_tone | 1.54400235 |
| 42 | MP0003123_paternal_imprinting | 1.49474266 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.49169785 |
| 44 | MP0004811_abnormal_neuron_physiology | 1.48177305 |
| 45 | MP0003283_abnormal_digestive_organ | 1.47398917 |
| 46 | MP0002066_abnormal_motor_capabilities/c | 1.34616964 |
| 47 | MP0003121_genomic_imprinting | 1.33462452 |
| 48 | MP0003122_maternal_imprinting | 1.33310967 |
| 49 | MP0004145_abnormal_muscle_electrophysio | 1.29983120 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.25950501 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.25641703 |
| 52 | MP0004484_altered_response_of | 1.23117507 |
| 53 | MP0000955_abnormal_spinal_cord | 1.22833573 |
| 54 | MP0001502_abnormal_circadian_rhythm | 1.22507798 |
| 55 | MP0002882_abnormal_neuron_morphology | 1.21844341 |
| 56 | MP0000778_abnormal_nervous_system | 1.19851219 |
| 57 | MP0004036_abnormal_muscle_relaxation | 1.19436116 |
| 58 | MP0003633_abnormal_nervous_system | 1.18714218 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.18269405 |
| 60 | MP0004085_abnormal_heartbeat | 1.15522749 |
| 61 | MP0005551_abnormal_eye_electrophysiolog | 1.11876938 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.11058948 |
| 63 | MP0004147_increased_porphyrin_level | 1.08815780 |
| 64 | MP0003329_amyloid_beta_deposits | 1.07039945 |
| 65 | MP0000013_abnormal_adipose_tissue | 1.06334152 |
| 66 | MP0004858_abnormal_nervous_system | 1.04671620 |
| 67 | MP0008872_abnormal_physiological_respon | 1.03689379 |
| 68 | MP0002229_neurodegeneration | 1.02559407 |
| 69 | MP0006072_abnormal_retinal_apoptosis | 0.98996422 |
| 70 | MP0004084_abnormal_cardiac_muscle | 0.98869130 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 0.98571199 |
| 72 | MP0003631_nervous_system_phenotype | 0.97539394 |
| 73 | MP0003137_abnormal_impulse_conducting | 0.96491952 |
| 74 | MP0005379_endocrine/exocrine_gland_phen | 0.96427966 |
| 75 | MP0005535_abnormal_body_temperature | 0.94648303 |
| 76 | MP0003690_abnormal_glial_cell | 0.94000773 |
| 77 | MP0008874_decreased_physiological_sensi | 0.93717325 |
| 78 | MP0002693_abnormal_pancreas_physiology | 0.93595177 |
| 79 | MP0003195_calcinosis | 0.89838265 |
| 80 | MP0004742_abnormal_vestibular_system | 0.89210965 |
| 81 | MP0002102_abnormal_ear_morphology | 0.88274395 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.85918801 |
| 83 | MP0004233_abnormal_muscle_weight | 0.84718763 |
| 84 | MP0001944_abnormal_pancreas_morphology | 0.84670811 |
| 85 | MP0003011_delayed_dark_adaptation | 0.84191035 |
| 86 | MP0008877_abnormal_DNA_methylation | 0.84095073 |
| 87 | MP0004043_abnormal_pH_regulation | 0.83841506 |
| 88 | MP0002152_abnormal_brain_morphology | 0.83325486 |
| 89 | MP0002069_abnormal_eating/drinking_beha | 0.82043072 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 0.81302139 |
| 91 | MP0000749_muscle_degeneration | 0.80612347 |
| 92 | MP0005448_abnormal_energy_balance | 0.79840411 |
| 93 | MP0002139_abnormal_hepatobiliary_system | 0.78481741 |
| 94 | MP0005620_abnormal_muscle_contractility | 0.77700995 |
| 95 | MP0000920_abnormal_myelination | 0.77291044 |
| 96 | MP0002972_abnormal_cardiac_muscle | 0.74128053 |
| 97 | MP0004885_abnormal_endolymph | 0.73954286 |
| 98 | MP0002090_abnormal_vision | 0.73710508 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.72316871 |
| 100 | MP0002078_abnormal_glucose_homeostasis | 0.71697665 |
| 101 | MP0000639_abnormal_adrenal_gland | 0.71148628 |
| 102 | MP0002638_abnormal_pupillary_reflex | 0.70364041 |
| 103 | MP0010329_abnormal_lipoprotein_level | 0.69042801 |
| 104 | MP0005332_abnormal_amino_acid | 0.68977536 |
| 105 | MP0005499_abnormal_olfactory_system | 0.68240351 |
| 106 | MP0005394_taste/olfaction_phenotype | 0.68240351 |
| 107 | MP0001664_abnormal_digestion | 0.67461191 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.67321293 |
| 109 | MP0005171_absent_coat_pigmentation | 0.67031249 |
| 110 | MP0004130_abnormal_muscle_cell | 0.66922154 |
| 111 | MP0002752_abnormal_somatic_nervous | 0.66544801 |
| 112 | MP0005253_abnormal_eye_physiology | 0.66188508 |
| 113 | MP0004510_myositis | 0.65249123 |
| 114 | MP0002332_abnormal_exercise_endurance | 0.63689633 |
| 115 | MP0006036_abnormal_mitochondrial_physio | 0.63663475 |
| 116 | MP0005409_darkened_coat_color | 0.62496301 |
| 117 | MP0001485_abnormal_pinna_reflex | 0.61972655 |
| 118 | MP0005636_abnormal_mineral_homeostasis | 0.60713912 |
| 119 | MP0001177_atelectasis | 0.59862247 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.58293529 |
| 121 | MP0005330_cardiomyopathy | 0.54875320 |
| 122 | MP0003634_abnormal_glial_cell | 0.54300377 |
| 123 | MP0003632_abnormal_nervous_system | 0.52923208 |
| 124 | MP0001943_abnormal_respiration | 0.52508626 |
| 125 | MP0008775_abnormal_heart_ventricle | 0.50515823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.46626811 |
| 2 | Myokymia (HP:0002411) | 5.81323339 |
| 3 | Atonic seizures (HP:0010819) | 5.71061216 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.62267452 |
| 5 | Febrile seizures (HP:0002373) | 5.61650580 |
| 6 | Focal seizures (HP:0007359) | 5.39120865 |
| 7 | Absence seizures (HP:0002121) | 4.71568521 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.45617886 |
| 9 | Visual hallucinations (HP:0002367) | 4.41808152 |
| 10 | Dialeptic seizures (HP:0011146) | 4.19669048 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.05201126 |
| 12 | Hyperventilation (HP:0002883) | 3.82650983 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 3.66204654 |
| 14 | Pheochromocytoma (HP:0002666) | 3.50638561 |
| 15 | Hypothermia (HP:0002045) | 3.30977240 |
| 16 | Broad-based gait (HP:0002136) | 3.29873187 |
| 17 | Action tremor (HP:0002345) | 3.16855312 |
| 18 | Dysmetric saccades (HP:0000641) | 3.14286278 |
| 19 | Intention tremor (HP:0002080) | 3.13686385 |
| 20 | Dysdiadochokinesis (HP:0002075) | 3.13563780 |
| 21 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.12274545 |
| 22 | Neuroendocrine neoplasm (HP:0100634) | 3.11812840 |
| 23 | Acute necrotizing encephalopathy (HP:0006965) | 3.11575291 |
| 24 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.04172121 |
| 25 | Ketoacidosis (HP:0001993) | 2.99807037 |
| 26 | Truncal ataxia (HP:0002078) | 2.99408673 |
| 27 | Poor eye contact (HP:0000817) | 2.93894164 |
| 28 | Progressive inability to walk (HP:0002505) | 2.93208096 |
| 29 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.88430425 |
| 30 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.88430425 |
| 31 | Progressive macrocephaly (HP:0004481) | 2.85413092 |
| 32 | Amblyopia (HP:0000646) | 2.84601912 |
| 33 | Anxiety (HP:0000739) | 2.81220642 |
| 34 | Abnormality of the corticospinal tract (HP:0002492) | 2.80252214 |
| 35 | Abnormal eating behavior (HP:0100738) | 2.78747675 |
| 36 | Scanning speech (HP:0002168) | 2.77999640 |
| 37 | Depression (HP:0000716) | 2.77219853 |
| 38 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.74063292 |
| 39 | Dysmetria (HP:0001310) | 2.72291671 |
| 40 | Epileptiform EEG discharges (HP:0011182) | 2.71335449 |
| 41 | Papilledema (HP:0001085) | 2.70543169 |
| 42 | Impaired social interactions (HP:0000735) | 2.69068638 |
| 43 | Abnormal social behavior (HP:0012433) | 2.69068638 |
| 44 | Abnormal hair whorl (HP:0010721) | 2.59905860 |
| 45 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.59116005 |
| 46 | Impaired smooth pursuit (HP:0007772) | 2.55761796 |
| 47 | Hypoglycemic seizures (HP:0002173) | 2.51558509 |
| 48 | Ventricular fibrillation (HP:0001663) | 2.51228478 |
| 49 | Inability to walk (HP:0002540) | 2.50558316 |
| 50 | Postural instability (HP:0002172) | 2.48697278 |
| 51 | Postural tremor (HP:0002174) | 2.47315146 |
| 52 | EEG with generalized epileptiform discharges (HP:0011198) | 2.45275518 |
| 53 | Poor suck (HP:0002033) | 2.44733117 |
| 54 | Mitochondrial inheritance (HP:0001427) | 2.43972408 |
| 55 | Akinesia (HP:0002304) | 2.43735288 |
| 56 | Ankle clonus (HP:0011448) | 2.41444086 |
| 57 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.38518935 |
| 58 | Abnormality of binocular vision (HP:0011514) | 2.36636229 |
| 59 | Diplopia (HP:0000651) | 2.36636229 |
| 60 | Gait imbalance (HP:0002141) | 2.31204715 |
| 61 | Acute encephalopathy (HP:0006846) | 2.28374913 |
| 62 | Status epilepticus (HP:0002133) | 2.27959824 |
| 63 | Genetic anticipation (HP:0003743) | 2.27916884 |
| 64 | Hypoglycemic coma (HP:0001325) | 2.27820079 |
| 65 | Bundle branch block (HP:0011710) | 2.27332642 |
| 66 | Supranuclear gaze palsy (HP:0000605) | 2.24164153 |
| 67 | Fetal akinesia sequence (HP:0001989) | 2.23095190 |
| 68 | Impaired vibratory sensation (HP:0002495) | 2.23061893 |
| 69 | Bradykinesia (HP:0002067) | 2.22729858 |
| 70 | Sudden death (HP:0001699) | 2.22342008 |
| 71 | Syncope (HP:0001279) | 2.22190468 |
| 72 | Muscular hypotonia of the trunk (HP:0008936) | 2.22069110 |
| 73 | Increased CSF lactate (HP:0002490) | 2.21346804 |
| 74 | Drooling (HP:0002307) | 2.21344047 |
| 75 | Excessive salivation (HP:0003781) | 2.21344047 |
| 76 | Hypsarrhythmia (HP:0002521) | 2.20421996 |
| 77 | Polyphagia (HP:0002591) | 2.17983735 |
| 78 | Absent speech (HP:0001344) | 2.17454076 |
| 79 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.17452874 |
| 80 | Exercise-induced myalgia (HP:0003738) | 2.16389341 |
| 81 | Failure to thrive in infancy (HP:0001531) | 2.16056147 |
| 82 | Congenital primary aphakia (HP:0007707) | 2.13075172 |
| 83 | Limb dystonia (HP:0002451) | 2.12787819 |
| 84 | Cerebral hypomyelination (HP:0006808) | 2.11752793 |
| 85 | Hepatocellular necrosis (HP:0001404) | 2.10269691 |
| 86 | Medial flaring of the eyebrow (HP:0010747) | 2.09136848 |
| 87 | Hemiparesis (HP:0001269) | 2.07262212 |
| 88 | Agitation (HP:0000713) | 2.06815520 |
| 89 | Hyperglycemia (HP:0003074) | 2.06680517 |
| 90 | Prolonged QT interval (HP:0001657) | 2.04847068 |
| 91 | Resting tremor (HP:0002322) | 2.04653682 |
| 92 | Nephrogenic diabetes insipidus (HP:0009806) | 2.03835975 |
| 93 | Atrial fibrillation (HP:0005110) | 2.02099314 |
| 94 | Abnormal EKG (HP:0003115) | 2.00808489 |
| 95 | Central scotoma (HP:0000603) | 2.00638228 |
| 96 | Oligomenorrhea (HP:0000876) | 2.00375023 |
| 97 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.99571282 |
| 98 | Urinary urgency (HP:0000012) | 1.98597866 |
| 99 | Primary atrial arrhythmia (HP:0001692) | 1.97843142 |
| 100 | Generalized myoclonic seizures (HP:0002123) | 1.96592811 |
| 101 | Large for gestational age (HP:0001520) | 1.96325954 |
| 102 | Optic disc pallor (HP:0000543) | 1.94986370 |
| 103 | Incomplete penetrance (HP:0003829) | 1.94672635 |
| 104 | Sleep apnea (HP:0010535) | 1.93322072 |
| 105 | Hemiplegia (HP:0002301) | 1.93193034 |
| 106 | Horizontal nystagmus (HP:0000666) | 1.92542137 |
| 107 | Spastic gait (HP:0002064) | 1.91034606 |
| 108 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.90903620 |
| 109 | Abnormality of alanine metabolism (HP:0010916) | 1.90903620 |
| 110 | Hyperalaninemia (HP:0003348) | 1.90903620 |
| 111 | Diminished movement (HP:0002374) | 1.89195562 |
| 112 | Torticollis (HP:0000473) | 1.87666198 |
| 113 | Supraventricular tachycardia (HP:0004755) | 1.87646965 |
| 114 | Craniofacial dystonia (HP:0012179) | 1.87508968 |
| 115 | Left ventricular hypertrophy (HP:0001712) | 1.87414190 |
| 116 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.86214612 |
| 117 | Spastic tetraplegia (HP:0002510) | 1.86182677 |
| 118 | Blue irides (HP:0000635) | 1.85380503 |
| 119 | Abnormality of saccadic eye movements (HP:0000570) | 1.84804167 |
| 120 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.84515378 |
| 121 | Focal dystonia (HP:0004373) | 1.84479535 |
| 122 | Calf muscle hypertrophy (HP:0008981) | 1.83447494 |
| 123 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.82810340 |
| 124 | Gait ataxia (HP:0002066) | 1.81594365 |
| 125 | Mutism (HP:0002300) | 1.81461588 |
| 126 | Termporal pattern (HP:0011008) | 1.81339098 |
| 127 | Delusions (HP:0000746) | 1.77968495 |
| 128 | Type II lissencephaly (HP:0007260) | 1.75398601 |
| 129 | Ketosis (HP:0001946) | 1.74502382 |
| 130 | Methylmalonic acidemia (HP:0002912) | 1.68840006 |
| 131 | Choreoathetosis (HP:0001266) | 1.67441708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.22047527 |
| 2 | CASK | 3.93364494 |
| 3 | MAP3K4 | 3.70012340 |
| 4 | MAP2K7 | 3.55761408 |
| 5 | EPHA4 | 3.50651782 |
| 6 | FRK | 3.49904690 |
| 7 | MAP3K12 | 3.26027754 |
| 8 | MAP3K9 | 2.70454397 |
| 9 | CDK19 | 2.44495921 |
| 10 | MINK1 | 2.34366153 |
| 11 | DAPK2 | 2.32178570 |
| 12 | MAP2K4 | 2.16977666 |
| 13 | RIPK4 | 2.08506145 |
| 14 | PLK2 | 1.99008992 |
| 15 | BMPR1B | 1.95160970 |
| 16 | DAPK1 | 1.90765787 |
| 17 | PRPF4B | 1.86250354 |
| 18 | CSNK1G2 | 1.80526647 |
| 19 | PAK6 | 1.68765790 |
| 20 | AKT3 | 1.64740952 |
| 21 | CSNK1G3 | 1.63505621 |
| 22 | MARK1 | 1.61518458 |
| 23 | CSNK1G1 | 1.59171819 |
| 24 | GRK5 | 1.53065776 |
| 25 | FGFR2 | 1.52905736 |
| 26 | NME1 | 1.38990803 |
| 27 | OXSR1 | 1.32334901 |
| 28 | CCNB1 | 1.30297768 |
| 29 | CDK5 | 1.29799614 |
| 30 | PDK4 | 1.29145525 |
| 31 | PDK3 | 1.29145525 |
| 32 | NTRK2 | 1.28629705 |
| 33 | PRKCG | 1.28168542 |
| 34 | CAMKK2 | 1.25370687 |
| 35 | SIK3 | 1.23666974 |
| 36 | BMPR2 | 1.23253669 |
| 37 | ARAF | 1.20982659 |
| 38 | CAMKK1 | 1.18424323 |
| 39 | CAMK2A | 1.16812677 |
| 40 | SGK2 | 1.16544777 |
| 41 | STK38 | 1.16512416 |
| 42 | FES | 1.16232409 |
| 43 | PNCK | 1.14916148 |
| 44 | TNIK | 1.14800156 |
| 45 | PINK1 | 1.14479707 |
| 46 | MAP3K2 | 1.13762268 |
| 47 | CSNK1A1L | 1.12940027 |
| 48 | MAPK13 | 1.10279052 |
| 49 | LMTK2 | 1.09775583 |
| 50 | SGK223 | 1.08755049 |
| 51 | SGK494 | 1.08755049 |
| 52 | KSR2 | 1.06285949 |
| 53 | GRK7 | 1.05537437 |
| 54 | NTRK1 | 1.03167539 |
| 55 | PHKG1 | 1.02868563 |
| 56 | PHKG2 | 1.02868563 |
| 57 | NEK1 | 1.00029406 |
| 58 | SIK2 | 0.99814703 |
| 59 | TSSK6 | 0.99240898 |
| 60 | KSR1 | 0.97580000 |
| 61 | MAP3K13 | 0.92228514 |
| 62 | MAP3K11 | 0.91775557 |
| 63 | PRKD3 | 0.90892170 |
| 64 | CAMK2B | 0.90726074 |
| 65 | TRIM28 | 0.90308347 |
| 66 | WNK3 | 0.88141590 |
| 67 | MAP4K2 | 0.85447362 |
| 68 | CAMK1 | 0.84171678 |
| 69 | SGK3 | 0.82680277 |
| 70 | MYLK | 0.81138829 |
| 71 | WNK1 | 0.79193952 |
| 72 | PTK2B | 0.76997938 |
| 73 | CAMK2D | 0.76967675 |
| 74 | CDK18 | 0.76364173 |
| 75 | TNK2 | 0.75674142 |
| 76 | ALK | 0.74983143 |
| 77 | PRKCE | 0.74376737 |
| 78 | PRKCH | 0.73808203 |
| 79 | STK11 | 0.73129034 |
| 80 | PRKCZ | 0.70774607 |
| 81 | CDK15 | 0.70443042 |
| 82 | CDK14 | 0.68780498 |
| 83 | PDK2 | 0.68044851 |
| 84 | PDK1 | 0.67694384 |
| 85 | UHMK1 | 0.66498085 |
| 86 | BRAF | 0.66421273 |
| 87 | SGK1 | 0.64432395 |
| 88 | LIMK1 | 0.61187185 |
| 89 | ACVR1B | 0.60344398 |
| 90 | CDK11A | 0.59153582 |
| 91 | CAMK2G | 0.57944146 |
| 92 | ERBB3 | 0.57782238 |
| 93 | DYRK1A | 0.57532393 |
| 94 | PDPK1 | 0.57089831 |
| 95 | CSNK1D | 0.55663836 |
| 96 | MUSK | 0.55031137 |
| 97 | GRK1 | 0.54753373 |
| 98 | CSNK1A1 | 0.53914315 |
| 99 | CDC42BPA | 0.53913598 |
| 100 | DAPK3 | 0.50941704 |
| 101 | PAK3 | 0.49900526 |
| 102 | PRKG1 | 0.49795415 |
| 103 | STK24 | 0.49255154 |
| 104 | NEK6 | 0.49183525 |
| 105 | TESK1 | 0.47903795 |
| 106 | CSNK1E | 0.45394241 |
| 107 | STK39 | 0.45202933 |
| 108 | CAMK4 | 0.44773926 |
| 109 | MAP3K1 | 0.44180742 |
| 110 | FER | 0.43983069 |
| 111 | MAPKAPK5 | 0.42700269 |
| 112 | PRKACA | 0.42489587 |
| 113 | CDK3 | 0.40977165 |
| 114 | RPS6KA3 | 0.39958446 |
| 115 | WNK4 | 0.39395803 |
| 116 | PKN1 | 0.38453044 |
| 117 | MAP2K6 | 0.38203255 |
| 118 | RET | 0.37118284 |
| 119 | ADRBK1 | 0.37049468 |
| 120 | PRKCB | 0.36748311 |
| 121 | RAF1 | 0.36670791 |
| 122 | INSRR | 0.36063633 |
| 123 | ROCK2 | 0.35928506 |
| 124 | MAPK7 | 0.35827118 |
| 125 | BCR | 0.35214034 |
| 126 | PRKG2 | 0.34894981 |
| 127 | LATS2 | 0.34085840 |
| 128 | ADRBK2 | 0.34026778 |
| 129 | MAP2K1 | 0.33740123 |
| 130 | DYRK2 | 0.33607944 |
| 131 | PRKCA | 0.32196977 |
| 132 | MAPK12 | 0.31934803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.15281831 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.01019686 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.87516547 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.82638009 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.70403261 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.60265254 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.59958315 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.53259377 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.45104104 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.45025478 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.36763341 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.35099083 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11918736 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.08517327 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.01280935 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 2.00742671 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 2.00126946 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.80819746 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.77245111 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.73421686 |
| 21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.70648179 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.69707661 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.68320758 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68256079 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.67967388 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.62611994 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.61072387 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55323522 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.55093059 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.55012809 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.54868003 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.52975685 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.51822029 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.48900459 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.47989778 |
| 36 | Alzheimers disease_Homo sapiens_hsa05010 | 1.39454455 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.34359383 |
| 38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.30544798 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.27974528 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23142699 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15945870 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.15494327 |
| 43 | Protein export_Homo sapiens_hsa03060 | 1.13929613 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.10381947 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10370184 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09753694 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04719632 |
| 48 | Gap junction_Homo sapiens_hsa04540 | 1.03816176 |
| 49 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02078042 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00475711 |
| 51 | Huntingtons disease_Homo sapiens_hsa05016 | 0.96999062 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.96460333 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.92806398 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.88457272 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87782516 |
| 56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87383578 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82253572 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81566233 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80743724 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.76081193 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75606693 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73850549 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.73387532 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72717152 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72055872 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.68896744 |
| 67 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.66623079 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66265072 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66076758 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65377879 |
| 71 | Glioma_Homo sapiens_hsa05214 | 0.65319077 |
| 72 | Melanogenesis_Homo sapiens_hsa04916 | 0.65185439 |
| 73 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64275706 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63993354 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63557530 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63107004 |
| 77 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.61477073 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.60206239 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.59537262 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59386162 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58454684 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58274121 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57241930 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56803280 |
| 85 | Axon guidance_Homo sapiens_hsa04360 | 0.56019470 |
| 86 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55250780 |
| 87 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.54609578 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54397215 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54039590 |
| 90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53477663 |
| 91 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.52298541 |
| 92 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51241103 |
| 93 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.49967283 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49782473 |
| 95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49475534 |
| 96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49009627 |
| 97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48458494 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46424798 |
| 99 | Phagosome_Homo sapiens_hsa04145 | 0.43708931 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43429727 |
| 101 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42543176 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42542348 |
| 103 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42490769 |
| 104 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42236724 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41604534 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41154698 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38994252 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.37714365 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36726140 |
| 110 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.34492969 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33333101 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32960967 |
| 113 | Alcoholism_Homo sapiens_hsa05034 | 0.32014383 |
| 114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.31585288 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31418301 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29806652 |
| 117 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.29475273 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29125929 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29058720 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28876702 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25973166 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.25668909 |
| 123 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.24408170 |
| 124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22079610 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21809315 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.20800572 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20366966 |
| 128 | Melanoma_Homo sapiens_hsa05218 | 0.19819616 |
| 129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.17749472 |
| 130 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.17424926 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16422327 |
| 132 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.16028502 |
| 133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.15741333 |

